[基于合成视网胺Am80的差异化诱导和吸入粉末开发的COPD治疗方法]
1Department of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences, Tokyo University of Science.
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
|January 5, 2025
概括
慢性阻塞性肺病 (COPD) 需要新的治疗方法来修复气膜破坏. 研究人员发现了合成视网体Am80并开发了一种用于膜再生疗法的药物输送系统.
科学领域:
- 再生医学是一种再生医学.
- 肺部医学 肺部医学
- 药物输送系统 药物输送系统
背景情况:
- 慢性阻塞性肺病 (COPD) 涉及慢性支气管炎和肺气,目前的治疗只提供症状缓解.
- 在COPD中,膜破坏需要新的治疗策略,重点是组织再生.
- 膜上皮原生细胞具有再生损坏的肺组织的潜力.
研究的目的:
- 通过专注于膜上皮原生细胞的分化来探索COPD的膜再生疗法.
- 开发一种药物输送系统 (DDS),以有效地将再生药物输送到气泡干细胞.
- 确定和评估诱导气泡膜再生的候选药物.
主要方法:
- 发现使用人类膜上皮原生细胞的新型膜再生药物.
- 开发一种药物输送系统 (DDS),利用生物机制来增强治疗效果.
- 干粉吸入系统的配方设计,用于向药物输送.
主要成果:
- 合成视网胺Am80的鉴定作为一个有希望的候选药物用于膜再生.
- 成功建造了一种旨在提高膜再生效率的DDS.
- 开发一种干粉吸入配方,用于有效的药物输送.
结论:
- 气泡膜再生疗法通过向气泡膜干细胞来治疗COPD具有前景.
- 通过专门的DDS和干粉吸入输送的合成视网胺Am80代表了对COPD的新治疗方法.
- 这种DDS和药物组合的进一步开发可能会导致COPD患者肺气泡破坏的有效治疗方法.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
117
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
117
Inhaled Medications
195
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
195
Drugs Used in Lower Respiratory Disorders: Overview
241
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
241
COPD: Pathogenesis and Clinical Features
168
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
168
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
131
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
131
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


